Hemophilia B Clinical Trials

ReadTheTrial indexes 2 studies for Hemophilia B. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Hemophilia B.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials for Hemophilia B

BeCoMe-9: A Phase 1/2 Dose Escalation and Expansion Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

NCT06611436 · RECRUITING · Phase 2

A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B

NCT06379789 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Hemophilia B?

There are 2 clinical trials listed for Hemophilia B. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Hemophilia B trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Hemophilia B trials in?

Current Hemophilia B trials are distributed across: Phase 2 (2).

Find More Trials